Search results
FDA approves a second Alzheimer's drug that can modestly slow disease
Associated Press Finance via Yahoo Finance UK· 6 days agoThe Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of...
Will the Tories ever recover from this defeat?
The New Statesman· 6 days agoThis was an election campaign that – from a Conservative perspective – was all about damage limitation. Perhaps left-wing electors might get their sense...
Jubilation from the French Left on the streets of Paris
The New Statesman· 17 hours agoThe crowds, which had begun to gather at Place de la République as the final voters headed to the...
The Conservatives invited this disaster
The New Statesman· 4 days agoThis is an election result that leaves the Conservative Party fighting for its life. The oldest and most successful political party in the country –...
FDA approves second Alzheimer’s drug that can modestly slow disease
Irish Examiner· 6 days agoRolling coverage of the international stories of interest to our readers
InnovationRx: A Fourth Dairy Worker Has Contracted Avian Flu
Forbes· 6 days agoInnovationRx is your weekly digest of healthcare news. Today, the Colorado Department of Public...
Viking (VKTX) Skyrockets 197% YTD: Is the Stock Worth a Buy?
Zacks via Yahoo Finance UK· 6 days agoDespite having no marketed drugs, Viking's (VKTX) stock continues to experience robust price...
S&P 500 Closes Above 5,500 in Record-Breaking Run: Markets Wrap
Bloomberg via Yahoo Finance UK· 6 days ago(Bloomberg) -- Wall Street traders sent stocks to all-time highs as bond yields fell, with traders...
Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows
Reuters· 3 days agoPatients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of...
Bankers Investment Trust: Why TSMC is a safer bet than Nvidia | Trustnet
TrustNet· 4 days agoGlobal stock markets have become obsessed with a narrow group of winners, such as chipmaker Nvidia and obesity drug manufacturers Novo Nordisk and Eli Lilly
